Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000734038 | SCV000862149 | pathogenic | not provided | 2018-06-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003574807 | SCV004292573 | pathogenic | Qualitative or quantitative defects of dysferlin | 2023-06-02 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 597804). This premature translational stop signal has been observed in individual(s) with Miyoshi myopathy (PMID: 16891820). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys1103*) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). |
Baylor Genetics | RCV004569419 | SCV005060279 | pathogenic | Miyoshi muscular dystrophy 1 | 2024-01-18 | criteria provided, single submitter | clinical testing |